Nevertheless, TLR9 has recently been shown to exacerbate SLE pathogenesis via a MYD88-dependent pathway, while simultaneously protect against SLE via a MYD88-independent pathway in B cells26. This evidence concerns the gene MYD88 and systemic lupus erythematosus.